Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Design Therapeutics Inc (DSGN)

Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Design Therapeutics Inc 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 USA

www.designtx.com P: 858-293-4900

Description:

Design Therapeutics Inc. is a biotechnology company. It involved in developing a platform of gene targeted chimera small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions. Design Therapeutics Inc. is based in CARLSBAD, Calif.

Key Statistics

Overview:

Market Capitalization, $K 210,161
Enterprise Value, $K 188,961
Shares Outstanding, K 56,495
Annual Sales, $ 0 K
Annual Net Income, $ -66,860 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,840 K
EBIT, $ -78,190 K
EBITDA, $ -83,740 K
60-Month Beta 1.83
% of Insider Shareholders 27.80%
% of Institutional Shareholders 56.64%
Float, K 40,789
% Float 72.20%
Short Volume Ratio 0.35

Growth:

1-Year Return -51.85%
3-Year Return -84.12%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 03/19/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -1.20
EPS Growth vs. Prev Qtr 25.00%
EPS Growth vs. Prev Year 32.26%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DSGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -22.81%
Return-on-Assets % -21.82%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.74
Book Value/Share 4.96
Interest Coverage -2.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar